Published in J Clin Lab Anal on January 01, 2004
Human body fluid proteome analysis. Proteomics (2006) 2.39
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics (2010) 1.90
CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics. Proteomics Clin Appl (2008) 1.57
Label-free quantitative proteomics reveals differentially regulated proteins influencing urolithiasis. Mol Cell Proteomics (2011) 0.90
Current peptidomics: applications, purification, identification, quantification, and functional analysis. Proteomics (2015) 0.85
The Human Urinary Proteome Fingerprint Database UPdb. Int J Proteomics (2013) 0.82
A novel mass spectrometry-based assay for GSK-3beta activity. BMC Biochem (2005) 0.77
Immunological evaluation of urinary trypsin inhibitors in blood and urine: role of N- & O-linked glycoproteins. Glycoconj J (2007) 0.76
SELDI-TOF derived serum biomarkers failed to differentiate between patients with beryllium sensitisation and patients with chronic beryllium disease. Occup Environ Med (2011) 0.75
Endogenous biotin expression in renal and testicular tumours and literature review. Can Urol Assoc J (2014) 0.75
Urine proteomic analysis in cystinuric children with renal stones. J Pediatr Urol (2015) 0.75
Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc Natl Acad Sci U S A (2002) 5.07
Microbiome profiling by illumina sequencing of combinatorial sequence-tagged PCR products. PLoS One (2010) 3.51
Potential uses of probiotics in clinical practice. Clin Microbiol Rev (2003) 2.80
Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst (2002) 2.77
Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res (2008) 2.63
Deep sequencing of the vaginal microbiota of women with HIV. PLoS One (2010) 2.59
Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res (2002) 2.36
Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res (2004) 2.33
In vivo magnetic resonance imaging of single cells in mouse brain with optical validation. Magn Reson Med (2006) 2.32
A novel drug eluting ureteral stent: a prospective, randomized, multicenter clinical trial to evaluate the safety and effectiveness of a ketorolac loaded ureteral stent. J Urol (2010) 2.21
Does tumour dormancy offer a therapeutic target? Nat Rev Cancer (2010) 2.19
Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases. Breast Cancer Res Treat (2003) 2.14
Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. Eur J Cancer (2010) 2.13
Percutaneous nephrolithotomy made easier: a practical guide, tips and tricks. BJU Int (2007) 2.09
Percutaneous management of calculi within horseshoe kidneys. J Urol (2003) 2.04
Evaluation of the bacterial vaginal flora of 20 postmenopausal women by direct (Nugent score) and molecular (polymerase chain reaction and denaturing gradient gel electrophoresis) techniques. J Infect Dis (2002) 1.91
Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation. Appl Environ Microbiol (2003) 1.89
In vivo MRI of cancer cell fate at the single-cell level in a mouse model of breast cancer metastasis to the brain. Magn Reson Med (2006) 1.88
Characterization and expression analysis of Staphylococcus aureus pathogenicity island 3. Implications for the evolution of staphylococcal pathogenicity islands. J Biol Chem (2002) 1.88
Holmium:YAG laser lithotripsy for upper urinary tract calculi in 598 patients. J Urol (2002) 1.82
Cancer spread and micrometastasis development: quantitative approaches for in vivo models. Bioessays (2002) 1.76
Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach. Scand J Infect Dis (2005) 1.75
Repression of the Staphylococcus aureus accessory gene regulator in serum and in vivo. J Bacteriol (2002) 1.73
Multicenter experience with metallic ureteral stents for malignant and chronic benign ureteral obstruction. J Endourol (2010) 1.72
The biology of metastasis to a sanctuary site. Clin Cancer Res (2007) 1.72
Quantitative determination by real-time PCR of four vaginal Lactobacillus species, Gardnerella vaginalis and Atopobium vaginae indicates an inverse relationship between L. gasseri and L. iners. BMC Microbiol (2007) 1.66
The CROES percutaneous nephrolithotomy global study: the influence of body mass index on outcome. J Urol (2012) 1.59
Changes over time of extracellular domain of HER2 (ECD/HER2) serum levels have prognostic value in metastatic breast cancer. Breast Cancer Res Treat (2008) 1.59
New dual monoclonal ELISA for measuring plasma osteopontin as a biomarker associated with survival in prostate cancer: clinical validation and comparison of multiple ELISAs. Clin Chem (2009) 1.59
Ureteroscopy and holmium:YAG laser lithotripsy: an emerging definitive management strategy for symptomatic ureteral calculi in pregnancy. Urology (2002) 1.57
Lactobacillus vaginal microbiota of women attending a reproductive health care service in Benin city, Nigeria. Sex Transm Dis (2006) 1.54
Dormancy of solitary metastatic cells. Cell Cycle (2006) 1.53
Role of the metastasis-promoting protein osteopontin in the tumour microenvironment. J Cell Mol Med (2010) 1.53
Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes Infect (2006) 1.52
Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: an overview of enabling science and potential applications. FEMS Microbiol Ecol (2005) 1.50
A triple-blinded randomized trial comparing the hemostatic effects of large-dose 10% hydroxyethyl starch 264/0.45 versus 5% albumin during major reconstructive surgery. Anesth Analg (2005) 1.49
Serial plasma osteopontin levels have prognostic value in metastatic breast cancer. Clin Cancer Res (2006) 1.49
Plasma osteopontin: associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma. Cancer (2002) 1.49
Osteopontin overexpression in breast cancer: knowledge gained and possible implications for clinical management. J Cell Biochem (2007) 1.48
Risk factors for perinephric hematoma formation after shockwave lithotripsy: a matched case-control analysis. J Endourol (2012) 1.47
Minimizing symptoms in patients with ureteric stents. Curr Opin Urol (2006) 1.45
Sensibility following innervated free TRAM flap for breast reconstruction: Part II. Innervation improves patient-rated quality of life. Plast Reconstr Surg (2009) 1.42
Lactobacillus strains and vaginal ecology. JAMA (2002) 1.41
Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation. Mol Cancer (2007) 1.40
The use of triclosan eluting stents effectively reduces ureteral stent symptoms: a prospective randomized trial. BJU Int (2012) 1.40
Beta-catenin signaling in fibroproliferative disease. J Surg Res (2006) 1.37
Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12. Appl Environ Microbiol (2006) 1.36
Detection of Atopobium vaginae in postmenopausal women by cultivation-independent methods warrants further investigation. J Clin Microbiol (2004) 1.35
Surgical simulation: a urological perspective. J Urol (2008) 1.34
Percutaneous nephrolithotomy for staghorn calculi: a single center's experience over 15 years. J Endourol (2009) 1.33
Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients. J Clin Gastroenterol (2008) 1.33
A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines. J Nutr (2004) 1.32
Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect (2006) 1.31
Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics. Future Microbiol (2009) 1.31
Structures of two streptococcal superantigens bound to TCR beta chains reveal diversity in the architecture of T cell signaling complexes. Structure (2002) 1.31
Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer. Am J Pathol (2006) 1.30
At the crossroads of vaginal health and disease, the genome sequence of Lactobacillus iners AB-1. Proc Natl Acad Sci U S A (2010) 1.30
Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435. Clin Exp Metastasis (2006) 1.30
Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways. Oncogene (2003) 1.29
Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome. Nat Med (2009) 1.29
Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis. Breast Dis (2007) 1.28
Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius. Antonie Van Leeuwenhoek (2006) 1.28
Osteopontin induces multiple changes in gene expression that reflect the six "hallmarks of cancer" in a model of breast cancer progression. Mol Carcinog (2005) 1.28
Comparative meta-RNA-seq of the vaginal microbiota and differential expression by Lactobacillus iners in health and dysbiosis. Microbiome (2013) 1.28
Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays. Breast Cancer Res (2008) 1.27
Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: novel post-transcriptional, post-translational regulation. Clin Exp Metastasis (2006) 1.26
Long-range cooperative binding effects in a T cell receptor variable domain. Proc Natl Acad Sci U S A (2006) 1.26
Bacterial superantigens bypass Lck-dependent T cell receptor signaling by activating a Galpha11-dependent, PLC-beta-mediated pathway. Immunity (2006) 1.26
A Canadian Working Group report on fecal microbial therapy: microbial ecosystems therapeutics. Can J Gastroenterol (2012) 1.25
Reporting of harm in randomized controlled trials published in the urological literature. J Urol (2010) 1.25
Randomized prospective blinded study validating acquistion of ureteroscopy skills using computer based virtual reality endourological simulator. J Urol (2002) 1.25
Beta(3) integrin expression increases breast carcinoma cell responsiveness to the malignancy-enhancing effects of osteopontin. Mol Cancer Res (2003) 1.24
Microbiota of human breast tissue. Appl Environ Microbiol (2014) 1.24
Tumour dormancy in breast cancer: an update. Breast Cancer Res (2007) 1.23
G-CSF-mediated inhibition of JNK is a key mechanism for Lactobacillus rhamnosus-induced suppression of TNF production in macrophages. Cell Microbiol (2006) 1.23
β1-integrin: a potential therapeutic target in the battle against cancer recurrence. Clin Cancer Res (2011) 1.23
Probiotic yogurt consumption is associated with an increase of CD4 count among people living with HIV/AIDS. J Clin Gastroenterol (2010) 1.22
A new model for lymphatic metastasis: development of a variant of the MDA-MB-468 human breast cancer cell line that aggressively metastasizes to lymph nodes. Clin Exp Metastasis (2005) 1.20
The role of apoptosis in tumor progression and metastasis. Curr Mol Med (2003) 1.20
The use of stents in contemporary urology. Curr Opin Urol (2004) 1.20
Brain metastases of breast cancer. Breast Dis (2007) 1.20
Steroid injections in the management of trigger fingers. Am J Phys Med Rehabil (2006) 1.20
Percutaneous antegrade endopyelotomy: long-term results from one institution. Urology (2004) 1.19
Transcriptional regulation of osteopontin and the metastatic phenotype: evidence for a Ras-activated enhancer in the human OPN promoter. Clin Exp Metastasis (2003) 1.18
Dietary genistein reduces metastasis in a postsurgical orthotopic breast cancer model. Cancer Res (2005) 1.18
Notch1 inhibition alters the CD44hi/CD24lo population and reduces the formation of brain metastases from breast cancer. Mol Cancer Res (2011) 1.18
Pre- and post-translational regulation of osteopontin in cancer. J Cell Commun Signal (2011) 1.17
Oxalate-degrading enzymes from Oxalobacter formigenes: a novel device coating to reduce urinary tract biomaterial-related encrustation. J Endourol (2003) 1.16